Effects of adjunctive pimavanserin and current antipsychotic treatment on QT interval prolongation in patients with schizophrenia
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.892199
Abstract: Background Pimavanserin prolongs the QT interval, with mean increases in corrected QT (QTc) of 5–8 ms, and is currently being investigated for the treatment of negative symptoms of schizophrenia. Objectives To assess QT interval prolongation… read more here.
Keywords: prolongation; antipsychotic treatment; postbaseline; adjunctive pimavanserin ... See more keywords